Proof of Concept (POC) in Patients With Ischaemic Stroke

Clinical trial NCT01808261 · TERMINATED

Trial details

NCT number: NCT01808261
Sponsor: GlaxoSmithKline
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Cerebrovascular Accident

Start date: 2013-05-18
Primary completion: 2014-07-28
Enrollment: 134

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.